[BRNS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -47.48%
YoY- 280.86%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 334 468 6,457 6,165 17,063 15,018 -1 -
PBT -24,960 -18,739 -23,182 7,547 14,774 1,711 -15,139 39.68%
Tax -1,136 -516 -2,019 -674 -915 -863 32 -
NP -23,802 -18,180 -21,189 8,242 15,693 2,596 -15,113 35.47%
Tax Rate - - - 8.93% 6.19% 50.44% - -
Total Cost 24,136 18,648 27,646 -2,077 1,370 12,422 15,112 36.75%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -7,126.35 -3,884.62 -328.16 133.69 91.97 17.29 1,511,300.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.62 -0.48 -0.56 0.22 0.42 0.07 0.00 -
EPS Diluted -0.62 -0.48 -0.56 0.22 0.41 0.07 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.